Skip to main content

Advertisement

SpringerLink
Log in

Does hormonal therapy decrease tamoxifen associated hot flashes?

  • Invited Commentary
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

The Original Article was published on 13 January 2009

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Osborne CR, Duncan A, Sedlacek S, Paul D, Holmes F, Vukelja S, Kasper M, Wilks S, Schneider A, McGee R, Meyer WG, O’Shaughnessy JA (2009) The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer. Breast Cancer Res Treat. doi:10.1007/s10549-008-0284-y

  2. Bardia A, Novotny P, Sloan J, Barton D, Loprinzi C (2009) Efficacy of non-estrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis. Menopause (in press)

  3. Loprinzi C, Zahasky K, Sloan J, Novotny P, Quella S (2000) Tamoxifen-induced hot flashes. Clin Breast Cancer 1(1):52–56. doi:10.3816/CBC.2000.n.004

    Article  PubMed  CAS  Google Scholar 

  4. Sestak I, Kealy R, Edwards R, Forbes J, Cuzick J (2006) Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms. J Clin Oncol 24(24):3991–3996. doi:10.1200/JCO.2005.04.3745

    Article  PubMed  CAS  Google Scholar 

  5. Loprinzi CL, Michalak JC, Quella SK, O’Fallon JR, Hatfield AK, Nelimark RA, Dose AM, Fischer T, Johnson C, Klatt NE et al (1994) Megestrol acetate for the prevention of hot flashes. N Engl J Med 331(6):347–352. doi:10.1056/NEJM199408113310602

    Article  PubMed  CAS  Google Scholar 

  6. Loprinzi CL, Levitt R, Barton D, Sloan JA, Dakhil SR, Nikcevich DA, Bearden JD 3rd, Mailliard JA, Tschetter LK, Fitch TR et al (2006) Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: north central cancer treatment group trial N99C7. J Clin Oncol 24(9):1409–1414. doi:10.1200/JCO.2005.04.7324

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA

    Debra L. Barton & Charles L. Loprinzi

Authors
  1. Debra L. Barton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles L. Loprinzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles L. Loprinzi.

Additional information

This is a comment to doi:10.1007/s10549-008-0284-y.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barton, D.L., Loprinzi, C.L. Does hormonal therapy decrease tamoxifen associated hot flashes?. Breast Cancer Res Treat 116, 529–530 (2009). https://doi.org/10.1007/s10549-009-0319-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-009-0319-z

Keywords

Search

Navigation